MATISSE CAPITAL – Kala Pharmaceuticals, Inc. Transaction History
MATISSE CAPITAL portfolio value:
$0
portfolio value
MATISSE CAPITAL quarter portfolio value change:
-26.20%
quarter
Kala Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -736 shares | -11K | $0.22 | 0 |
| Q2 2022 | share | 0.00% | 0 shares | -40K | $0.3 | 36.8K | |
| Q1 2022 | share | Decrease | -11.11% | -4.6K shares | 1K | $1.38 | 36.8K |
| Q4 2021 | share | Decrease | -26.20% | -14.7K shares | -97K | $1.22 | 41.4K |
| Q3 2021 | share | 0.00% | 0 shares | -150K | $2.62 | 56.1K | |
| Q2 2021 | share | 0.00% | 0 shares | -81K | $5.3 | 56.1K | |
| Q1 2021 | share | Increase | +0.54% | 300 shares | 0 | $6.74 | 56.1K |
| Q4 2020 | share | Increase | +10.93% | 5.5K shares | 1K | $6.78 | 55.8K |
| Q3 2020 | share | 0.00% | 0 shares | -152K | $7.5 | 50.3K | |
| Q2 2020 | share | Decrease | -37.98% | -30.8K shares | -184K | $10.51 | 50.3K |
| Q1 2020 | share | Increase | +48.81% | 26.6K shares | 512K | $8.79 | 81.1K |
| Q4 2019 | share | Increase | +17.20% | 8K shares | 24K | $3.69 | 54.5K |
| Q3 2019 | share | Increase | +4.49% | 2K shares | -107K | $3.81 | 46.5K |
| Q2 2019 | share | Increase | +1.83% | 800 shares | -77K | $6.38 | 44.5K |
| Q1 2019 | share | Increase | 0.00% | 43.7K shares | 361K | $8.27 | 43.7K |